Introduction

Visibility platforms, monitoring technologies, risk management tools, and analytics capabilities have become increasingly common across global operations. Yet despite this progress, many organizations continue to struggle with the same fundamental challenges: product excursions, lengthy investigations, slow approvals, and fragmented coordination across supply chain partners.

This report explores the gap between digital maturity and operational maturity, and examines what pharmaceutical supply chains may need to do differently to convert visibility into measurable operational value.